Addex Therapeutics to Present at Access to Giving Virtual Conference on July 14, 2021

Geneva, Switzerland, July 7, 2021 - Addex Therapeutics (SIX:ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that Chief Executive Officer, Tim Dyer, will present at Access to Giving Virtual Conference at 9 AM ET on July 14, 2021. Mr. Dyer will give a corporate update, including an overview of recent advances in Addex’s clinical trial program. The conference is free to all registrants.

See more here:
Addex Therapeutics to Present at Access to Giving Virtual Conference on July 14, 2021

Related Post